TREA

76374498 - BIOTEST

Follow

Information

  • Trademark
  • 76374498
  • Serial Number
    76374498
  • Registration Number
    2961650
  • Filing Date
    February 21, 2002
    23 years ago
  • Registration Date
    June 14, 2005
    19 years ago
  • Transaction Date
    August 30, 2011
    13 years ago
  • Status Date
    July 27, 2011
    13 years ago
  • Published for Opposition Date
    March 22, 2005
    20 years ago
  • Location Date
    July 27, 2011
    13 years ago
  • First Use Anywhere Date
    July 02, 1977
    47 years ago
  • First Use In Commerce Date
    October 05, 1997
    27 years ago
  • Status Code
    705
  • Employee Name
    EDWARDS, ALICIA COLLIN
  • Attorney Docket Number
    BTS-106US
    Attorney Name
    John W. McGlynn
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
BIOTEST
Case File Statements
  • DM0000: The mark consists of the word BIOTEST proximate a red triangle device with a red ball or circle at each of the vertices of the triangle device. The word portion of the mark is in black ink.
  • GS0011: [ In-vitro diagnostic preparations for scientific purposes; test kits comprising reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents for scientific and research purposes; systems for determining resistance for scientific purposes comprising nutrient media, cell culture media, and dried media; buffers, salts, solvents for research and scientific purposes; test kits comprising buffers, salts, solvents and reagents for industrial and scientific purposes for hygiene monitoring on surfaces, in air and liquids, and systems for identification of germs for scientific and research purposes comprising nutrient media, buffers and salts; DNA probes for tissue typing, germ or pathogen identification and blood group determination ]
  • GS0051: [ Pharmaceutical and veterinary preparations and products for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; food for babies; medical plasters; materials for wound, burn or surgical dressing; pharmaceutical preparations for hematology, oncology, transplantation medicine, nephrology, pediatrics, for intensive care medicine, namely, blood products, immune globulin preparations, globulin preparations, coagulation factors; medicines for use in transplantation procedures and for influencing blood coagulation; immune globulin preparations for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; serum preparations, and serum proteins and solutions comprising the same for medical use; human albumin for medical use; blood products for medical use, namely, blood plasma; blood substitutes; plasma substitutes and plasma expanders; vaccines, especially on basis of immune globulines; blood coagulation preparations, especially coagulation factors for clinical and medical laboratory use; antibiotics; medicines for treating the central nervous system; medicines for treating heart and circulation diseases; medicines for treating the respiratory system; medicines for urological treatment; medicines for treatment of digestive organs and corresponding/adjoining glands; hormones; vitamins; immunosuppressive, anti-inflammatory, and antiallergic medicines; dermatological, ophtalmological and otological medicines; in-vivo and in-vitro diagnostic preparations for clinical or medical purposes and clinical or medical laboratory use; antibodies, namely, mono- and polyclonal antibodies for use in in-vivo clinical and medical diagnostics and for patient therapy; in vitro diagnostic agents for medical purposes, especially for determination of proteins, such as antibodies, monoclonal antibodies or immune globulins, or for determinations of nucleic acids, for blood group diagnostics and antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, and determination of toxic compounds; test kits comprising ready to use nutrient media for microorganisms, especially bacteria, and reagents for medical and laboratory uses, especially for blood group diagnostics, antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic substances; test kits comprising monoclonal and polyclonal antibodies and natural and recombinant antigenes, for tests on serological and immune genetic basis, and reagents therefore for human and veterinary medical laboratory purposes; immunoassays such as ELISA's, consisting of reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents therefore for human and veterinary medical laboratory purposes; diagnostic preparations for human or veterinary medical uses in the treatment of infections; media for bacteriological cultures, namely, ready-to-use culture media and nutrient media and ingredients thereof ]
  • GS0091: [ Plates and multiwell microtiter plates for cell typing, blood and virus diagnostics; blood warmers; apparatus, namely, incubator, cell sorter, cell counter, shaker, pipettes, plates and vials for cell recovery and for handling of cells, including disposable materials; ] measuring and surveying apparatus, namely, [ sample holder, reader, photometer, centrifuge, shaker, incubator, washer, particle counter ] and air sampler for removal, determination and quantification of microorganisms in air, [ liquids ] and on surfaces; [ measuring and surveying kits/systems and agar strips for determination and quantification of substances, namely, blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for sanitary and hygiene monitoring, [ laboratory robot, for automated processing of microtiter plate based assays like ELISAs, DNA hybridization assays and cell agglutination tests; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for determination of particle size and number in air; kits/systems comprising air samplers, sample holders and reader for clean room air monitoring; all the foregoing for use in research and/or non-medical laboratories
  • GS0101: [ Medical, apparatus for clinical or diagnostic use, namely, apparatus for serological blood typing, blood grouping or serological detection of blood groups; bottles and containers specially designated for storage and conservation of solutions for transfusions and infusions; transfusion and infusion apparatus and devices, namely, containers, syringes, catheters, transdermal delivery systems comprising blood warmers and plasma for clinical use; apparatus for cell recovery and for handling of cells, including disposable materials, namely, plates, spatula, vials, pipette tips and beakers for clinical or diagnostic use; measuring and surveying apparatus for clinical and diagnostic use, namely, sample holder, reader, photometer, dipsticks, teststrips, and agar strips for determination and quantification of substances, especially blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; plates and multiwell microtiter plates for cell typing, blood and virus diagnostics for clinical and diagnostic use; all of the foregoing for medical, clinical, diagnostic and/or surgical use ]
  • LS0000: Color is a feature of the mark. The mark is lined for the color red.
Case File Event Statements
  • 7/28/2011 - 13 years ago
    32 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED Type: NA85
  • 7/27/2011 - 13 years ago
    31 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 7/27/2011 - 13 years ago
    30 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 6/14/2011 - 13 years ago
    29 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F
  • 7/26/2011 - 13 years ago
    28 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/14/2011 - 13 years ago
    27 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 11/3/2008 - 16 years ago
    26 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/3/2008 - 16 years ago
    25 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/23/2008 - 16 years ago
    24 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 10/23/2008 - 16 years ago
    23 - CANCELLATION TERMINATED NO. 999999 Type: CANT
  • 10/23/2008 - 16 years ago
    22 - CANCELLATION DISMISSED NO. 999999 Type: CAND
  • 1/6/2008 - 17 years ago
    21 - CANCELLATION INSTITUTED NO. 999999 Type: PETC
  • 6/14/2005 - 19 years ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/22/2005 - 20 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/2/2005 - 20 years ago
    18 - NOTICE OF PUBLICATION Type: NPUB
  • 12/29/2004 - 20 years ago
    17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/28/2004 - 20 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/24/2004 - 20 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/27/2004 - 20 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 8/25/2004 - 20 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 8/25/2004 - 20 years ago
    12 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 5/7/2004 - 20 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/7/2004 - 20 years ago
    10 - PAPER RECEIVED Type: MAIL
  • 2/9/2004 - 21 years ago
    9 - NON-FINAL ACTION MAILED Type: CNRT
  • 10/20/2003 - 21 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/17/2003 - 21 years ago
    7 - CASE FILE IN TICRS Type: CFIT
  • 10/20/2003 - 21 years ago
    6 - PAPER RECEIVED Type: MAIL
  • 4/24/2003 - 21 years ago
    5 - FINAL REFUSAL MAILED Type: CNFR
  • 1/16/2003 - 22 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/16/2003 - 22 years ago
    3 - PAPER RECEIVED Type: MAIL
  • 7/18/2002 - 22 years ago
    2 - NON-FINAL ACTION MAILED Type: CNRT
  • 6/14/2002 - 22 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK